PT - JOURNAL ARTICLE ED - BMJ Publishing Group Ltd TI - â–¼Pylorid, H. pylori and peptic ulcer AID - 10.1136/dtb.1996.34969 DP - 1996 Sep 01 TA - Drug and Therapeutics Bulletin PG - 69--70 VI - 34 IP - 9 4099 - http://dtb.bmj.com/content/34/9/69.short 4100 - http://dtb.bmj.com/content/34/9/69.full SO - Drug Ther Bull1996 Sep 01; 34 AB - Relevant BNF section: 1.3.1In most people with a duodenal or gastric ulcer, the stomach mucosa is infected with Helicobacter pylori.1 If this infection is eradicated the risk of ulcer relapse is greatly reduced. Ranitidine bismuth citrate (Pylorid - GlaxoWellcome) was licensed last year and promoted as a drug "designed to be used in combination with clarithromycin for effective eradication of H. pylori". How valuable is it in the management of peptic ulcer disease?